Login

BioMed Realty Bets on West Coast Markets for Life Science Space

Blackstone-Owned Firm Builds Pipeline Amid Rising Biotech Demand

BioMed Realty invested $92 million in the recently opened Center for Novel Therapeutics. (BioMed Realty)
BioMed Realty invested $92 million in the recently opened Center for Novel Therapeutics. (BioMed Realty)

The nation's second-largest owner of life science office and lab space, BioMed Realty, is placing big development bets on markets in the high-demand West Coast hubs of San Francisco, Seattle and San Diego, where it recently invested $92 million in a new oncology research incubator.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In